

Special Alerts:
[Posted 06/30/2011] A National Alert for Serious Medication Errors has been issued by the American Society of Health-System Pharmacists (ASHP) and the Institute for Safe Medication Practices (ISMP), warning that potentially fatal errors may occur with dosing for the antibiotic colistimethate for injection. The use of this drug has been increasing due to its value as a last resort treatment for multi-drug resistant organisms.
Colistimethate is a prodrug, a pre-cursor of a drug that converts to an active drug in the human body as it is metabolized. However, in the U.S., the strength of all FDA-approved colistimethate for injection products is labeled in terms of the base drug, colistin, not the prodrug. The label expresses the strength as 150 mg of colistin base per vial.
Dosing information also is expressed in terms of the colistin base. However, on the Internet and in some journal references, dosing information is based on the prodrug, colistimethate. This has resulted in situations where the prodrug dose is ordered but confused as a colistin dose, which results in doses approximately 2.5 times higher than intended.
In a recent case, a physician mistakenly ordered a dose of colistimethate as the prodrug, but the amount was dispensed as the colistin base. The patient developed complications including acute renal failure and later died.
The alert provides recommendations to prevent misdosing of colistimethate, which include developing dose limits, restricting prescribing to infectious disease specialists, and monitoring the patients’ renal function. Physicians, pharmacists, and nurses are expected to use these recommendations to take immediate action to prevent serious medication errors at their facility.
Alerts are issued by ASHP and ISMP when a significant risk for serious or fatal errors is detected through ISMP’s National Medication Error Reporting Program (MERP). Alerts are distributed to healthcare practitioners and organizations through ISMP, ASHP, and the National Council on Medication Error Reporting and Prevention.
Generic Name: colistimethate
Brand Names: Colistimethate Sodium, Coly Mycin M
This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.
Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):
This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.


